Confirmed Control Announced Transaction verified ConsumerDrug Delivery TechnologiesLife Sciences / Drug Delivery TechnologiesPharmaceutical Delivery Devices
Antares Pharma, Inc. acquired by Halozyme Therapeutics
Halozyme Therapeutics agreed to acquire Antares Pharma, Inc., a life sciences / drug delivery technologies brand on Apr 13, 2022. Financial terms were not publicly disclosed. The current comp implies EV / revenue of 4.9x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Antares Pharma, Inc.
- Acquirer
- Halozyme Therapeutics
- Seller
- -
- Announced
- 2022-04-13
- Geography
- -
- Tags
- ConsumerDrug Delivery TechnologiesLife Sciences / Drug Delivery TechnologiesPharmaceutical Delivery Devices
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
Undisclosed
Transaction value
Basis: FundComb estimate
EV / revenue
4.9x
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Financial terms were not disclosed in the public sources reviewed.
- EV / revenue is shown as 4.9x based on the available comp inputs.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
Source summary
No public source summary has been published for this transaction yet.